HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Fusion of H4/D10S170 to PDGFRbeta in a patient with chronic myelomonocytic leukemia and long-term responsiveness to imatinib.

AuthorsMatthias Drechsler, Barbara Hildebrandt, Andrea Kündgen, Ulrich Germing, Brigitte Royer-Pokora
JournalAnnals of hematology (Ann Hematol) Vol. 86 Issue 5 Pg. 353-4 (May 2007) ISSN: 0939-5555 [Print] Germany
PMID17211520 (Publication Type: Case Reports, Letter)
Chemical References
  • Benzamides
  • CCDC6 protein, human
  • Cytoskeletal Proteins
  • Mutant Chimeric Proteins
  • Piperazines
  • Protein Kinase Inhibitors
  • Pyrimidines
  • Imatinib Mesylate
  • Receptor, Platelet-Derived Growth Factor beta
Topics
  • Benzamides
  • Cytoskeletal Proteins (genetics)
  • Gene Fusion (drug effects)
  • Humans
  • Imatinib Mesylate
  • Leukemia, Myelomonocytic, Chronic (drug therapy, genetics)
  • Mutant Chimeric Proteins (analysis, drug effects, genetics)
  • Piperazines (pharmacology, therapeutic use)
  • Protein Kinase Inhibitors (pharmacology, therapeutic use)
  • Pyrimidines (pharmacology, therapeutic use)
  • Receptor, Platelet-Derived Growth Factor beta (genetics)
  • Translocation, Genetic (drug effects)

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: